Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2025-12-24 @ 5:19 PM
NCT ID:
NCT00529750
Eligibility Criteria:
Inclusion Criteria:
* Hypertension grade 1 or 2
* With at least two of the following criteria for the diagnosis of metabolic syndrome:
* Body mass index \> or = 25 kg/m2 AND waist circumference \> or = 100 cm.
* Dyslipidemia (triglycerides fasting serum levels \> or = 200 mg/dL OR HDL serum levels \< or = 40 mg/dL)
* Fasting serum glucose \> or = 110 mg/dL but \< 126 mg/dL
Exclusion Criteria:
* Known hypersensitivity to Irbesartan
* Hypertension grade 3
* History of clinical vascular events such as TIAs, stroke, peripheral arterial disease
* Coronary artery disease
* Renal insufficiency (creatinine serum levels \> or = 1.2 mg/dL)
* Presence of clinical heart failure
* Asthma and COPD
* Valvular cardiopathy clinically relevant
* Current therapy with antioxidant drugs, statins
* Therapy with AIIRA for at least 3 months during the last semester
* Presence of any acute illness or major trauma in the last 8 weeks
* History of a chronic inflammatory disease such as rheumatoid arthritis, immune disorders or connective tissue disease.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00529750
Study Brief:
Protocol Section:
NCT00529750